FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17191011000001103: Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
59929601000001116 Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92807101000001114 Arzerra 100mg/5ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Ofatumumab 100mg/5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Ofatumumab false Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Arzerra true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Ofatumumab true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 3 vial Has AMP True Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 10 vial Has AMP True Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start